Home

Research Centre on Vascular Ageing and Stroke
VASCage

R&D Centre

VASCage is a new and unique R&D Centre on Vascular Ageing and Clinical Stroke Research.

Science meets industry

We combine the international expertise of top scientists and leading research companies.

Our vision

is to extend the healthy lifespan in the ageing community by promoting vascular health.

Our strengths

  • outstanding clinical and epidemiological expertise
  • the alliance with several large hospitals
  • broad access to patients
  • an own clinical trial platform

Our shareholders

  • Medical University of Innsbruck
  • University of Innsbruck

OUR FIGHT AGAINST STROKE

  • ambitious prevention programs
  • improving diagnosis, therapy and rehabilitation
  • enabling better coping with the effects of stroke

News & Events

covid study VASCage

VASCage researchers find cardiometabolic microRNA biomarkers that may aid in COVID-19 severity and mortality prediction

The study was conducted by VASCage project leader Prof. Manuel Mayr and his team including first author and PhD student Dr. Clemens Gutmann, who studied and practiced medicine at the Medical University of Innsbruck before joining Prof. Mayr’s group at King’s College London. In collaboration with researchers from VASCage company partner TAmiRNA GmbH in Vienna they contribute with their recent findings to fight the pandemic. They have published their results in ‘Cardiovascular Research‘, the

PRESS RELEASE: Blood vessels already suffer in youth. New VASCage publication on cardiovascular risk factors in Journal JAHA

Risk factors for heart attack and stroke such as blood and liver fat levels lead to an increase in early pathological vascular wall changes in Tyrolean adolescents. This has been shown in a representative study of Tyrolean and South Tyrolean adolescents. A recent publication by the VASCage research center and the Medical University of Innsbruck concludes that preventive care would be important not only for high-risk adolescents.